(2S,2'S)-2,2'-([1,1'-Biphenyl]-4,4'-Diyldi-1H-Imidazole-5,2-Diyl)Bis-1-Pyrrolidinecarboxylic Acid 1,1'-Bis(1,1-Dimethylethyl) Ester

In palladium-mediated asymmetric allylic alkylation (AAA), the (2S,2'S)-2,2'-([1,1'-biphenyl]-4,4'-diyldi-1H-imidazole-5,2-diyl)bis-1-pyrrolidinecarboxylic acid 1,1'-bis(1,1-dimethylethyl) ester is combined with a Pd(II) precursor to generate a C₂-symmetric chiral pocket. A rigorously anhydrous preparation protocol is applied: the ligand (1.05 mol% relative to substrate) and [Pd(η³-allyl)Cl]₂ dimer (0.5 mol%) are dissolved in distilled dichloromethane (water content < 30 ppm by Karl Fischer titration, ISO 760:1978) under argon inside a dual-manifold Schlenk line evacuated to < 1 mbar and backfilled three times. After stirring at 23 °C for 40 min, the catalyst solution is added dropwise to a vessel containing racemic (E)-1,3-diphenylallyl acetate and the nucleophile, typically dimethyl malonate, pre-activated with N,O-bis(trimethylsilyl)acetamide (BSA) and anhydrous potassium acetate. The crucial processing window is the reaction temperature: optimizing at –20 ± 2 °C using a Huber Unistat Tango closed-loop chiller yields enantiomeric excesses (ee) consistently above 94 % (determined by HPLC on a Daicel Chiralpak AD-H column, hexane/2-propanol 90:10, 0.8 mL/min, ASTM D2244-22 instrumental principles). Even a temperature drift to –10 °C reduces ee by 6–9 percentage points, while prolonged holding beyond 24 h initiates ligand Boc-group cleavage, releasing free pyrrolidine that poisons metal sites and generates dibenzylideneacetone condensation byproducts detectable by 1H NMR at δ 3.2–3.5 ppm. The isolated chiral allylation product, after flash chromatography (silica, ethyl acetate/hexane gradients), serves as the critical C–C coupling intermediate en route to (R)-baclofen and related GABA_B agonists. Residual palladium in the downstream pharmaceutical intermediate is monitored by inductively coupled plasma mass spectrometry per USP 〈233〉, with a limit of < 10 µg/g consistent with ICH Q3D Option 1 for oral drug substances. On a 50-L glass-lined reactor at pilot scale, batch-to-batch ee fluctuation was reproduced within ±1.7 % over 13 consecutive runs, confirming the system’s sensitivity to stirring geometry and jacket temperature ramp rate.

What Limits the Enantiomeric Excess in Copper-Catalyzed Asymmetric Michael Additions Using C₂-Symmetric Bisimidazole Ligands?

The same protected ligand coordinates to Cu(II) acetate monohydrate (Cu(OAc)₂·H₂O) in absolute ethanol for the enantioselective Michael addition of cyclic β‑keto esters to nitroalkenes. Stoichiometric tuning is mandatory: a ligand-to-copper ratio of 1.2 : 1 is applied because the bifunctional imidazole‑pyrrolidine scaffold can temporarily deactivate copper through off‑cycle bridging if metal excess exceeds 5 mol‑%. The catalyst complex is formed in situ by dissolving 4.8 g of ligand and 1.8 g of Cu(OAc)₂·H₂O in 120 mL of ethanol, stirring at 40 °C for 30 min under nitrogen until a homogeneous deep‑blue solution emerges. After cooling to –5 °C, methyl 2-oxocyclopentanecarboxylate (1.0 equiv) and trans-β‑nitrostyrene (1.2 equiv) are introduced. Reaction progress is monitored by TLC (silica 60 F₂₅₄, hexane/ethyl acetate 3:1) and terminated at 85–92 % conversion to minimize retro‑Michael cleavage. The diastereomeric ratio (dr) routinely reaches > 20:1 (anti:syn), and ee of the major anti‑isomer, measured by supercritical fluid chromatography (SFC) on a Chiralpak IA‑3 column with CO₂/methanol (95:5) at 120 bar backpressure, falls in the range 88–96 % depending on the nitroalkene substituent. A critical limitation emerges with ortho‑substituted nitroalkenes: steric congestion at the imidazole‑phenyl torsion angle lowers ee to 72–81 %. Regulatory compliance for the Michael adduct, when intended as a precursor to pharmaceutically active chiral γ‑amino acids, adheres to ICH Q3C (residual ethanol and ethyl acetate quantified by headspace GC‑FID) and ICH M7 for nitrosamine risk assessment, since trace secondary amines can arise from premature Boc deprotection. The copper content in the final crystallized product is reduced to < 25 ppm by treatment with a metal‑scavenging functionalized silica gel (Silicycle SiliaMetS Thiol) and confirmed by ICP‑OES against NIST SRM 1640a. Isolated yields on a 20-L jacketed reactor with retreat‑curve impeller are 82–85 % after crystallization from tert‑butyl methyl ether/n-heptane.

Homochiral Metal–Organic Frameworks with Permanent Porosity for Liquid-Phase Separation of Racemic 1‑Phenylethylamine

Replacement of the tert‑butyl ester with a carboxylic acid handle allows the ligand to act as a strut in zirconium‑based homochiral MOFs. However, the intact Boc‑protected diester finds direct use as a precursor for in‑situ deprotection during solvothermal synthesis. In a representative protocol, the protected ligand (1.72 g, 2.5 mmol) and ZrCl₄ (0.53 g, 2.3 mmol) are suspended in N,N‑dimethylformamide (40 mL) containing formic acid (6.5 mL) and water (0.4 mL) inside a Teflon‑lined Parr acid digestion vessel. The vessel is heated to 120 °C at a ramp of 2 °C/min and held for 48 h. During this period, microwave‑assisted control experiments (CEM Discover SP, 200 W) revealed that Boc cleavage completes within 8–12 h, generating free pyrrolidine‑imidazole‑biphenyl linkers that assemble into a UiO‑type framework with fcu topology. After cooling and washing with DMF and methanol, activation by supercritical CO₂ drying (Polaron E3000, 40 °C, 100 bar) yields a microporous solid with BET specific surface area (ASTM D6556-21) of 920–1030 m²/g and a pore volume of 0.48–0.53 cm³/g. Powder X‑ray diffraction (Bragg‑Brentano geometry, Cu Kα, 2θ = 4–40°) confirms retention of the UiO‑67 isoreticular pattern. For enantioseparation, a 10 cm × 1 cm steel column packed with 1.8 g of MOF is equilibrated with n‑hexane/2-propanol (95:5). Injection of 20 µL racemic 1-phenylethylamine provides baseline resolution (α = 2.4) by circular dichroism detection at 254 nm. The framework’s chiral recognition is sensitive to trace moisture; operation above 35 % relative humidity induces linker hydrolysis and reduces selectivity by 40 % within 12 h. REACH Regulation (EC) No 1907/2006 annexes apply when the MOF is exported for analytical use, and the manufacturer must provide a SDS detailing silicon‑oxygen dust irritation potential (H‑Statement H319) and DMF residual solvent content confirmed below 0.08 wt% by thermogravimetric analysis coupled with mass spectrometry (TGA‑MS) at a 10 °C/min ramp to 350 °C.

Diastereomeric Resolution of BINOL-Derived Phosphoric Acids via Transient Imidazolium Salt Formation

The basic imidazole nitrogen atoms in the protected ligand enable a clean proton-transfer resolution sequence with enantiopure 1,1′-bi‑2‑naphthol (BINOL)‑derived phosphoric acids. While the Boc‑pyrrolidine esters remain untouched, the imidazole moieties react with (±)-BINOL phosphoric acid (1.0 equiv) in acetonitrile at 0 °C, forming a pair of diastereomeric imidazolium salts whose solubility profiles differ sharply. In an optimized batch at the 100-gram scale, the ligand (62 g, 0.1 mol) and racemic phosphoric acid (36 g) are dissolved in 500 mL of acetonitrile at 45 °C and allowed to cool to –10 °C over 6 h with precise linear cooling rate 0.10 °C/min controlled by a Lauda PRO bath with an external Pt100 probe. The salt incorporating the (R)-phosphoric acid crystallizes as colorless prisms, leaving the (S)-enantiomer enriched in the supernatant. Solid‑liquid separation through a Büchner funnel under nitrogen, followed by recrystallization from acetonitrile/toluene (1:2 v/v), affords the diastereomer with 99.2 % de (diastereomeric excess) determined by 1H NMR using the α‑naphthyl proton signal at δ 8.2–8.4 ppm and confirmed by chiral HPLC (Chiralpak IC, hexane/2-propanol/TFA 80:20:0.1). The ligand is recovered quantitatively by treatment with aqueous NaHCO₃ (10 % w/v) and extraction with ethyl acetate, showing unchanged optical rotation ([α]D²⁵ = –163° ± 2°, c 1.0, CHCl₃) meeting USP 〈781〉 methodology. This process requires rigorous exclusion of primary and secondary aliphatic amines from all solvents, as trace amines deprotonate the imidazolium site prematurely, collapsing selectivity. Phosphate contamination of the final phosphoric acid product is avoided by monitoring ³¹P NMR (δ –7.5 ppm for the acid, δ –5.9 ppm for the imidazolium phosphate ion). The resolved acid serves as a catalyst in asymmetric transfer hydrogenation, and the supplier’s certificate of analysis references compliance with ISO 9001:2015 clause 8.3 for design and development of custom resolution services.

In the synthesis of a chiral pyrrolidinyl‑imidazole intermediate en route to hepatitis C virus NS5A inhibitors, the protected ligand constitutes the core scaffold directly. Commercial manufacturing routes for agents such as daclatasvir and velpatasvir rely on a coupling between the biphenyl‑imidazole‑pyrrolidine terminus and a subsequent valine‑derived cap. The Boc‑protected diester is prepared in multi‑kilogram campaigns: the (S,S)-configured pyrrolidine‑carboxylic acid segments are first built by enzymatic resolution or Evans chiral auxiliary chemistry, then coupled to 4,4′-dibromomethylbiphenyl via a bis‑imidazole cyclization under Hantzsch conditions. Process‑scale hydrogenation in a 500-L Hastelloy C‑22 stirred autoclave (Parr Instrument Company) uses 5 % Pd/C (0.2 wt% loading) in tetrahydrofuran at 3 bar g hydrogen pressure and 50 °C to reduce any residual olefinic by‑products without affecting imidazole rings. Filtration through a 0.5 µm sintered metal candle under nitrogen and subsequent solvent swap to n‑heptane delivers the protected ligand with GC purity > 99.5 area% by European Pharmacopoeia method 2.2.28 and single unknown impurity below 0.10 %. Regulatory starting material designation under ICH Q11 requires detailed description of the control strategy for isomer impurities: the (R,R)-enantiomer and meso-diastereomer are individually quantified by SFC (Chiralpak AD‑H, CO₂/methanol 80:20, 40 °C) and each limited to < 0.15 %. The Boc groups are retained until the penultimate step to avoid intramolecular amidine formation between pyrrolidine and imidazole at high temperatures. Terminal deprotection uses HCl in dioxane (4 M) at 10–15 °C, and the resulting dihydrochloride salt is directly acylated with (S)-N‑methoxycarbonyl‑valine without isolation, ensuring overall GMP compliance per 21 CFR 211 subpart D (equipment) and subpart F (production records).

When a Fluorescence Turn‑On Sensor Monitors Free Zn²⁺ in Electroplating Effluents

Structural rigidity of the biphenyl‑bisimidazole core and the tertiary amine character of the pyrrolidine units confer a chelation‑enhanced fluorescence (CHEF) response upon complexation with zinc(II). For selective Zn²⁺ detection, the Boc‑protected ligand is first converted to a water‑compatible derivative through controlled acidic cleavage of one Boc group, then dissolved in HEPES‑buffered (10 mM, pH 7.4) aqueous 1,4‑dioxane (1:1 v/v). A stock solution of 2.5 × 10⁻⁵ M exhibits weak emission at 420 nm upon excitation at 320 nm (slit widths 5 nm/5 nm, JASCO FP‑8500 spectrofluorometer). Sequential additions of Zn(NO₃)₂ standard (NIST‑traceable, 1000 µg/mL) induce a 7-fold fluorescence enhancement with a binding constant log K = 8.3 ± 0.2 calculated by non‑linear regression of the Benesi‑Hildebrand plot at 420 nm. The linear working range covers 0.8–45 µg/L Zn²⁺, and a detection limit of 0.5 µg/L (s/n = 3) meets the discharge threshold of the German AbwV (Wastewater Ordinance) Annex 40. For real effluents from cyanide‑free alkaline zinc‑nickel plating lines, sample pre‑treatment includes digestion with nitric acid (EN ISO 15587-1:2002) and masking of interfering Cu²⁺ with thiourea at 0.1 M. Comparison with the reference EPA Method 200.7 (ICP‑OES) across 30 split samples gave a mean bias of +3.8 % and a Pearson r of 0.991, confirming sensor accuracy. The sensor cartridge is prepared by embedding the ligand derivative in a porous ethyl cellulose/PVC matrix and gluing the membrane onto a disposable polymethyl methacrylate optical cell, which can be coupled to a portable LED‑photodiode reader. Storage at 4 °C in the dark preserves response sensitivity for 6 months, but exposure to temperatures exceeding 40 °C irreversibly degrades fluorescence output by 70 % within 2 h, attributed to Boc thermolysis and pyrrolidine ring oxidation.